Altogen Labs, a biotechnology company focused on providing biotechnology research services for pharmaceutical, biotechnology, and academic institutions worldwide, announced pre-clinical contract research services enabling companies to accelerate pre-clinical research needs.
Pre-clinical trials assess the toxicity and pharmacological activity of investigative new drugs (INDs) to assess a compound’s therapeutic potential and safety for human use. A very important component of pre-clinical trials includes in vivo toxicology analysis. At Altogen Labs, in vivo toxicology studies can include acute, subchronic, and chronic toxicity tests to study of toxic effects of chemical substances.
To accelerate the development of new anti-cancer medicines, Altogen Labs now offers in vivo xenograft services for drug development studies to treat inflammation, infectious diseases, cancer, pain, immunology and obesity. As a GLP-compliant laboratory, animal handling is IACUC-regulated and in accordance with FDA regulations. A variety of disease models are now available for testing.
Altogen Labs excels in providing excellent preservation and maintenance of cell banks. Cell viability is ensured by our redundant backup system in our secure, monitored and controlled storage facility. Cell banking services include maintenance and around the clock monitoring of cell bank environments, providing clients with cell lines free of bacterial and mycoplasma contamination.
Altogen labs, also provides generation of stable cell line services from start to finish. The development of stable cell lines is a necessity to science today and provides researchers with the ability to design, create, and characterize stable cell lines that express a gene of interest. Although this process is time consuming, at Altogen Labs the generation of stable cell lines can take as little as 6-12 weeks.
By offering RNA Interference (RNAi) services, Altogen Labs provide clients with RNAi gene silencing in vivo and in vitro services from beginning to end. These services include the design and development of stable siRNA, shRNA, and miRNA cell lines, RNAi delivery, siRNA transfection, quantification of knockdown or amplification effects, in vitro functional testing, and gene targeting.
About Altogen Labs
Altogen Labs is a contract research organization (CRO) providing biotechnology research services for pharmaceutical, biotechnology, and academic institutions worldwide. Altogen Labs services include skilled laboratory CRO pre-clinical research, including generation of stable cell lines and tissue culture testing services, in vivo toxicology studies for IND applications, biodistribution studies and xenograft animal models, gene expression analysis, as well as tissue-targeted in vivo RNAi and siRNA delivery services. Altogen Labs is headquartered in Austin, TX. For more information, please visit http://altogenlabs.com/ or call us 512-433-6177.